Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olfactory mucosa-derived MSCs for Laryngotracheal Stenosis
NCT05535803Phase 2Unknown
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of olfactory mucosa-derived mesenchymal stem cells in Laryngotracheal stenosis (LTS). Status: unknown.
02
Drugs
olfactory mucosa-derived mesenchymal stem cells
03
Conditions
Laryngotracheal stenosis (LTS)
Beyond the preview
Go deeper on NCT05535803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05535803.